The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Amgen strikes Enbrel 'outcomes' contract with Harvard Pilgrim

Roche lawsuit blasts Amgen for 'about-face' on biosimilar patent fights

Would Pfizer, Roche or Novartis megamerge with BMS? Rumors say they're crunching numbers now

Amgen's Repatha wins in outcomes trial, but is the score high enough?

Amgen sets 'reasonable expectations' with lower 2017 sales guidance: analyst

After a contentious review, cost watchdog ICER rolls out updates to framework

Amgen claims Sanofi, Regeneron 'resort to hyperbole,' 'scare tactics' in PCSK9 appeal

Is the PCSK9 patent fight giving Amgen's Repatha a boost? Script numbers say so